GlassScriptPhysician profile
Danielle N Hebert
NPI 1194275271
$13,901.65
in general payments reported to CMS, 2019-2025
48 companies · $2,722 in 2025
The $2,722 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,665 · 2022: $3,615 · 2023: $3,192 · 2024: $2,708 · 2025: $2,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,608 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,607.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,024.41 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,668.47 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,191.86 | 2021-2025 | |
| Lilly USA, LLC | $1,049.79 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $1,019.40 | 2021-2025 | |
| Glaxosmithkline, LLC. | $680.65 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lucid Diagnostics INC. | $660.33 | 2022-2025 | |
| Amgen INC. | $514.96 | 2021-2025 | Otezla, Repatha, Repatha |
| Biohaven Pharmaceuticals, INC. | $488.96 | 2021 | |
| Gilead Sciences, INC. | $436.45 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $407.18 | 2022 | |
| Bausch Health US, LLC | $376.45 | 2023-2025 | Aplenzin |
| Exact Sciences Corporation | $366.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $305.14 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.52 | 2021-2025 | Jardiance |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $241.77 | 2022-2025 | |
| Dynavax Technologies Corporation | $222.94 | 2024-2025 | Heplisav-B |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $207.20 | 2022-2025 | Xifaxan, Ibschek |
| Currax Pharmaceuticals LLC | $186.28 | 2021-2025 | Contrave, Nexlizet, Nexletol |
| Dexcom, INC. | $163.12 | 2022-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $161.58 | 2021-2022 | |
| Shield Therapeutics INC | $133.79 | 2023-2024 | Accrufer |
| Corium, LLC | $114.08 | 2022-2025 | Azstarys |
| Idorsia Pharmaceuticals US INC | $111.29 | 2022-2024 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $108.94 | 2023-2025 | |
| Amarin Pharma, INC. | $104.66 | 2021-2022 | |
| Noven Therapeutics, LLC | $75.80 | 2023-2024 | Xelstrym |
| Sanofi-Aventis U.S. LLC | $67.70 | 2023-2025 | |
| Boston Scientific Corporation | $53.07 | 2025 | Watchman Access System, General - Pain Management |
| Merck Sharp & Dohme LLC | $42.66 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Horizon Therapeutics Plc | $38.90 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $35.36 | 2021-2022 | |
| Neos Therapeutics, LP | $34.83 | 2021-2022 | |
| Phadia US INC. | $31.84 | 2021-2022 | |
| Axsome Therapeutics, INC. | $28.93 | 2025 | Auvelity |
| Antares Pharma, INC. | $28.48 | 2022 | |
| Cleerly, INC. | $27.00 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Ibsa Pharma INC. | $24.83 | 2022 | |
| Neuronetics, INC. | $24.74 | 2025 | Neurostar Tms Therapy System |
| Upsher-Smith Laboratories LLC | $24.02 | 2022 | |
| Si-Bone, INC. | $23.55 | 2024 | |
| Alk-Abello, INC | $22.21 | 2025 | Neffy, Odactra, Grastek |
| Qiagen, LLC | $21.97 | 2022 | |
| Adlon Therapeutics L.P. | $17.58 | 2021 | |
| Eisai INC. | $16.88 | 2021 | |
| Axonics, INC. | $15.92 | 2022 | |
| Kaleo, INC. | $14.09 | 2022 | |
| Medicure Pharma INC. | $13.85 | 2024 | Zypitamag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Hebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.